Synthesis and evaluation of a new class of nifedipine analogs with T-type calcium channel blocking activity
- PMID: 11854446
- DOI: 10.1124/mol.61.3.649
Synthesis and evaluation of a new class of nifedipine analogs with T-type calcium channel blocking activity
Abstract
We have synthesized a novel series of 18 dialkyl 1,4-dihydro-4-(2'alkoxy-6'-pentadecylphenyl)-2,6-dimethyl-3,5 pyridine dicarboxylates from anacardic acid, a natural compound found in cashew nut shells, and investigated their blocking action on L- and T-type calcium channels transiently expressed in tSA-201 cells. The IC(50) values for L-type calcium channel block obtained with the series ranged from 1 to approximately 40 microM, with higher affinities being favored by increasing the size of the alkoxy group on the 4-phenyl ring and ester substituent in the 3,5 positions. A detailed analysis of the strongest L-type channel blocker of the series (PPK-12) revealed that block was poorly reversible and mediated an apparent speeding of the time course of inactivation. Moreover, in the presence of PPK-12, the midpoint of the steady state inactivation curve was shifted by 20 mV toward more hyperpolarized potentials, resulting in an increase in blocking efficacy at more depolarized holding potentials. Surprisingly, PPK-12 blocked T- and L-type calcium channels with similar affinities. One of the weakest L-type channel inhibitors (PPK-5) exhibited a T-type channel affinity that was similar to that seen with PPK-12, resulting in a 40-fold selectivity of PPK-5 for T- over L-type channels. Thus, dialkyl 1,4-dihydro-4-(2'alkoxy-6'-pentadecylphenyl)-2,6-dimethyl-3,5 pyridine dicarboxylates may serve as excellent candidates for the development of T-type calcium-channel specific blockers.
Similar articles
-
L, P-/Q- and T-type Ca2+ channels in smooth muscle cells from human umbilical artery.Cell Physiol Biochem. 2007;20(1-4):55-64. doi: 10.1159/000104153. Cell Physiol Biochem. 2007. PMID: 17595515
-
Synthesis and SAR studies of a novel series of T-type calcium channel blockers.Bioorg Med Chem. 2006 May 15;14(10):3502-11. doi: 10.1016/j.bmc.2006.01.005. Epub 2006 Jan 24. Bioorg Med Chem. 2006. PMID: 16434203
-
Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.Bioorg Med Chem. 2004 Aug 1;12(15):3965-70. doi: 10.1016/j.bmc.2004.06.011. Bioorg Med Chem. 2004. PMID: 15246072
-
T-type calcium channel blockers as neuroprotective agents.Pflugers Arch. 2014 Apr;466(4):757-65. doi: 10.1007/s00424-014-1454-x. Epub 2014 Feb 25. Pflugers Arch. 2014. PMID: 24563219 Free PMC article. Review.
-
Synthesis of Dihydropyrimidines: Isosteres of Nifedipine and Evaluation of Their Calcium Channel Blocking Efficiency.Molecules. 2023 Jan 12;28(2):784. doi: 10.3390/molecules28020784. Molecules. 2023. PMID: 36677842 Free PMC article. Review.
Cited by
-
Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.Pflugers Arch. 2014 Jul;466(7):1355-63. doi: 10.1007/s00424-013-1376-z. Epub 2013 Oct 23. Pflugers Arch. 2014. PMID: 24149495
-
Nifedipine Upregulates ATF6-α, Caspases -12, -3, and -7 Implicating Lipotoxicity-Associated Renal ER Stress.Int J Mol Sci. 2020 Apr 29;21(9):3147. doi: 10.3390/ijms21093147. Int J Mol Sci. 2020. PMID: 32365658 Free PMC article.
-
Molecular pharmacology of high voltage-activated calcium channels.J Bioenerg Biomembr. 2003 Dec;35(6):491-505. doi: 10.1023/b:jobb.0000008022.50702.1a. J Bioenerg Biomembr. 2003. PMID: 15000518 Review.
-
Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.ACS Chem Neurosci. 2015 Feb 18;6(2):277-87. doi: 10.1021/cn500206a. Epub 2014 Nov 5. ACS Chem Neurosci. 2015. PMID: 25314588 Free PMC article.
-
Targeting voltage-gated calcium channels in neurological and psychiatric diseases.Nat Rev Drug Discov. 2016 Jan;15(1):19-34. doi: 10.1038/nrd.2015.5. Epub 2015 Nov 6. Nat Rev Drug Discov. 2016. PMID: 26542451 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials